However, CXCL13 is also increased in NMO and other neuroinflammatory diseases [78], and patients with viral/bacterial infections show extremely high CXCL13 levels [79], therefore, due to low specificity, this chemokine is not suitable as a diagnostic biomarker. The gene discussed is CXCL13; the disease is neuromyelitis optica.